AU509948B2 - Halogenated derivatives of 16 alphamethyl pregnant - Google Patents

Halogenated derivatives of 16 alphamethyl pregnant

Info

Publication number
AU509948B2
AU509948B2 AU22808/77A AU2280877A AU509948B2 AU 509948 B2 AU509948 B2 AU 509948B2 AU 22808/77 A AU22808/77 A AU 22808/77A AU 2280877 A AU2280877 A AU 2280877A AU 509948 B2 AU509948 B2 AU 509948B2
Authority
AU
Australia
Prior art keywords
alphamethyl
pregnant
halogenated derivatives
halogenated
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU22808/77A
Other languages
English (en)
Other versions
AU2280877A (en
Inventor
J. G. Costerousse G. and Berardi R Fouts ah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of AU2280877A publication Critical patent/AU2280877A/en
Application granted granted Critical
Publication of AU509948B2 publication Critical patent/AU509948B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU22808/77A 1976-03-02 1977-03-01 Halogenated derivatives of 16 alphamethyl pregnant Expired AU509948B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7605854A FR2342738A1 (fr) 1976-03-02 1976-03-02 Nouveaux derives halogenes de la serie du 16a-methyl pregnane

Publications (2)

Publication Number Publication Date
AU2280877A AU2280877A (en) 1978-09-07
AU509948B2 true AU509948B2 (en) 1980-06-05

Family

ID=9169832

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22808/77A Expired AU509948B2 (en) 1976-03-02 1977-03-01 Halogenated derivatives of 16 alphamethyl pregnant

Country Status (16)

Country Link
JP (1) JPS52106855A (es)
AT (1) AT355237B (es)
AU (1) AU509948B2 (es)
BE (1) BE851944A (es)
CA (1) CA1082170A (es)
CH (1) CH619969A5 (es)
DE (1) DE2709078C2 (es)
DK (1) DK156401C (es)
FR (1) FR2342738A1 (es)
GB (1) GB1530975A (es)
IE (1) IE44866B1 (es)
LU (1) LU76867A1 (es)
NL (1) NL7702166A (es)
PT (1) PT66261B (es)
SE (1) SE7702250L (es)
ZA (1) ZA771078B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2462443A1 (fr) * 1979-07-26 1981-02-13 Roussel Uclaf Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament
FR2533928A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB928301A (en) * 1958-06-20 1963-06-12 Scherico Ltd 9, 11-dihalogeno steroids
US3049554A (en) * 1959-06-01 1962-08-14 Schering Corp 9, 11-dihalogeno-3, 20-diketopregnanes and processes for their manufacture

Also Published As

Publication number Publication date
FR2342738B1 (es) 1979-10-12
NL7702166A (nl) 1977-09-06
DK156401C (da) 1990-01-08
IE44866L (en) 1977-09-02
DK156401B (da) 1989-08-14
DE2709078C2 (de) 1986-09-11
CH619969A5 (en) 1980-10-31
SE7702250L (sv) 1977-09-03
JPS6150960B2 (es) 1986-11-06
PT66261A (fr) 1977-04-01
PT66261B (fr) 1979-01-17
CA1082170A (fr) 1980-07-22
FR2342738A1 (fr) 1977-09-30
AU2280877A (en) 1978-09-07
DK88277A (da) 1977-09-03
BE851944A (fr) 1977-09-01
IE44866B1 (en) 1982-04-21
AT355237B (de) 1980-02-25
ATA136577A (de) 1979-07-15
DE2709078A1 (de) 1977-09-08
ZA771078B (en) 1978-04-26
JPS52106855A (en) 1977-09-07
GB1530975A (en) 1978-11-01
LU76867A1 (es) 1977-09-26

Similar Documents

Publication Publication Date Title
AU508149B2 (en) Halogenated 1 Azolyl-butane derivatives
JPS52153964A (en) Preparation of benzimidazolonee*2*
AU512709B2 (en) Preparation of phenoxybenzaldehyde
AU2636877A (en) 4-Hydroxyphenylalkanolamine derivatives and preparation thereof
AU508171B2 (en) 4 hydroxy-aporphine derivatives
JPS52133978A (en) Preparation of 22aryllbenzoxazole or 22arylbenzthiazole
AU508791B2 (en) Indazolyl-(4)-oxypropanolamine derivatives
JPS5313690A (en) Preparation of homoo or coopolymer of alphaamonoolefin
JPS5323974A (en) Preparation of 55aminoo1*2*33thiadiazole
JPS5346974A (en) Preparation of thiazolinee*3*
AU509948B2 (en) Halogenated derivatives of 16 alphamethyl pregnant
JPS5293777A (en) Preparation of 1*22benzothiadinee33carboxyamide
AU505101B2 (en) Preparation of 7-alkoxy-3-chloromethylcephems
AU514875B2 (en) 17-acetylene derivatives of androst-4-ene
JPS52116485A (en) Preparation of 33phenylpyridazonee*6*
JPS5323937A (en) Preparation of paraaaminoarylamine or paraaalkylaminoarylamine
AU512322B2 (en) Derivatives of 2-phenyl-2-hydroxyethylamine
AU520387B2 (en) Preparation of 17 beta-hydroxy-3-oxo-17 alpha pregn-4 ene-21-carboxylic acid-gamma lactone
AU517707B2 (en) N-hydrazides of 2-benzo-thiazolinones
AU518954B2 (en) Derivatives of 9-chloroprednisolone
AU504351B2 (en) Preparation of hexachlorocyclobutene
AU505827B2 (en) Preparation of hydrazines
AU513066B2 (en) 3 amino-2hydroxy-propoxphenyl derivatives
AU510710B2 (en) 6-substituted derivatives of d 8-ergolin-1-ylacetamide
JPS52133986A (en) Derivative of antibiotic nanaomycina